🇺🇸 FDA

Company profile · Sponsor

Almirall

MIRA · NYSE pharma MIAMI, FL, EU
Pipeline
10
Drugs
6
Patents
8

Quick answer

Almirall (MIRA) is a pharma company. headquartered in MIAMI, FL, EU. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 6 drugs, and 8 patents to this profile..

Company facts

Ticker MIRA
Exchange NYSE
Company type pharma
Headquarters MIAMI, FL, EU
SEC CIK 0001904286

Pipeline (10)

Search pipeline →

  1. Ebglyss 250 mg solution for injection in pre-filled syringe, Placebo, Ebglyss 250 mg solution for injection in pre-filled pen

    Almirall

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  2. Placebo, Ebglyss 250 mg solution for injection in pre-filled syringe

    Almirall

    Nummular Dermatitis

    phase 3 small molecule active

    1 trial

  3. TIRBANIBULIN, Placebo of the new presentation of 350 mg/sachet drug product (hereafter referred as vehicle) is a smooth, creamy white to off-white ointment free from foreign particles, packed intact and properly sealed containing the same qualitative composition as the active product but without the active substance. The vehicle will be provided in a single-use packets to contain 350 mg of drug product., Klisyri 10 mg/g ointment

    Almirall

    Actinic Keratosis on the Face or Scalp

    phase 3 small molecule active

    1 trial

  4. LAD328, SODIUM CHLORIDE

    Almirall

    moderate-to-severe hidradenitis suppurativa

    phase 2 small molecule active

    1 trial

  5. Placebo for LAD603, LAD603

    Almirall

    Alopecia areata

    phase 2 small molecule active

    1 trial

  6. SODIUM CHLORIDE, ADALIMUMAB, LAD191, LAD191 placebo

    Almirall

    Moderate-to-severe hidradenitis suppurativa

    phase 2 small molecule active

    1 trial

  7. A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers.

    Almirall

    Inflammatory diseases

    phase 1 other active

    1 trial

  8. Almax Forte 1,5 g suspensión oral

    Almirall

    heartburn and or reflux

    approved small molecule active

    1 trial

  9. Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel

    Almirall

    Actinic Keratosis

    approved small molecule active

    1 trial

  10. Toujeo

    Almirall

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

Drugs (6)

Search drugs →

  1. azelaic acid

    AZELAIC ACID

    TOPICAL approved

  2. flurandrenolide

    CORDRAN N

    TOPICAL approved

  3. mequinol

    SOLAGE

    TOPICAL approved

  4. retapamulin

    ALTARGO

    TOPICAL approved

    D06AX13

  5. sarecycline hydrochloride

    SEYSARA

    ORAL approved

  6. tazarotene

    TAZAROTENE

    TOPICAL approved

Patents (8)

Search patents →

  1. US 12421228

    Naphthyridine derivatives as PRC2 inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12421253

    Tetrahydropyridopyrimidine pan-KRas inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12414911

    Topical compositions and methods of use

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12412764

    Substrate-accommodating container

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12398154

    Azaquinazoline pan-KRas inhibitors

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12383503

    Adagrasib solid pharmaceutical compositions

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12377101

    Combination therapies

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12371435

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Almirall?

Almirall (MIRA) is a pharma company. headquartered in MIAMI, FL, EU. listed on NYSE. NovaPharmaNews links 10 pipeline programs, 6 drugs, and 8 patents to this profile..

What pipeline programs does Almirall sponsor?

We track 10 ClinicalTrials.gov-linked programs for Almirall, including Ebglyss 250 mg solution for injection in pre-filled syringe, Placebo, Ebglyss 250 mg solution for injection in pre-filled pen and 9 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Almirall company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.